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The central nervous system is composed of the brain and the spinal cord. The brain is a complex organ that processes and
coordinates activities of the body in bilaterian, higher-order animals. The development of the brain mirrors its complex function
as it requires intricate genetic signalling at specific times, and deviations from this can lead to brain malformations such as
anencephaly. Research into how the CNS is specified and patterned has been studied extensively in chick, fish, frog, and mice, but
findings from the latter will be emphasised here as higher-order mammals show most similarity to the human brain. Specifically,
we will focus on the embryonic development of an important forebrain structure, the striatum (also known as the dorsal striatum
or neostriatum). Over the past decade, research on striatal development in mice has led to an influx of new information about
the genes involved, but the precise orchestration between the genes, signalling molecules, and transcription factors remains
unanswered. We aim to summarise what is known to date about the tightly controlled network of interacting genes that control
striatal development. This paper will discuss early telencephalon patterning and dorsal ventral patterning with specific reference
to the genes involved in striatal development.
1. Striatum: An Overview
The striatum plays a vital role in the coordination of move-
ment (primary motor control), emotions, and cognition [1–
3]. In humans, the striatum is divided into two nuclei, the
caudate and the putamen, by the internal capsule, whereas in
mice it is one structure. This is shown in Figure 1. The com-
plexity and importance of the striatum is best highlighted
when it is impaired. There are a number of diseases that
may produce striatal damage, including acquired conditions
such as a stroke and genetically inherited conditions such
as Huntington’s disease (HD). HD is a condition that is
characterised by neuronal dysfunction and neuronal loss that
principally aﬀects the medium spiny neurons (MSNs) of
the striatum. MSNs are the major projection neuron and
constitute the vast majority of neurons in this structure.
HD results in progressive deterioration of movement and
cognition and, in many cases, additional behavioural deficits
over a period of 15–30 years, and eventually renders an
individual unable to care for themselves. To date there is
little in the way of symptomatic treatment and no disease-
modifying agents available. A better understanding of striatal
development is likely to accelerate our understanding of
the pathogenic processes underlying conditions such as HD
and is central to the development of protocols to engineer
stem cells to be suitable as donor tissue for cell replacement
therapy [3–5].
2. Neuronal Development
Development of the nervous system starts with neural
induction, followed by neurulation that gives rise to the
neural tube, and finally, patterning of this tube along the
anterior-posterior (AP) axis. Following AP patterning, the
neural tube folds and is subdivided into the prosencephalon
(forebrain), the most anterior (rostral) part of the neural
tube, which consists of the telencephalon and diencephalon,
the mesencephalon (midbrain), and the rhombencephalon
(hindbrain) [6]. These major subdivisions are shown in
Figure 2. Regional patterning of the putative brain regions
is then controlled by a series of interacting gene networks, of
which the ones controlling telencephalic development are the
most complex.
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Figure 1: (a) Coronal section of a human brain showing the cortex, the caudate, and the putamen separately that when combined make up
the striatum in comparison to (b) a caudal section of a mouse brain stained with cresyl violet showing the striatum as one structure and the
cortex [1].
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Figure 2: Patterning of the neural tube. The neural plate folds
to form the neural tube, which comprises developing areas of
the CNS. The prosencephalon is split into the telencephalon and
diencephalon and the mesencephalon and rhombencephalon.
3. Regional Patterning of the
Developing Telencephalon
The embryonic telencephalon, which is located at the most
rostral end of the neural tube, is divided into the dorsal
telencephalon (also called pallium), which gives rise to the
neocortex, and the ventral telencephalon (also called the
subpallium), which forms the striatum and is the origin
of cells that populate the olfactory bulb, globus pallidus
(GP), and some cells that also populate the cortex [7]. This
paper will concentrate on the development of the ventral
telencephalon. Although the adult striatum is diﬀerent
between all mammalian species, the initial subdivisions
observed in the telencephalon are comparable [8, 9].
Due to the rapid migration of postmitotic neurons in the
subpallium, three prominent intraventricular bulges form;
the septum, the medial, and lateral ganglionic eminences
(MGE/LGE), collectively referred to as the whole ganglionic
eminence (WGE), shown in Figure 3. The MGE, the most
ventral eminence, gives rise to the amygdaloid body and the
GP whilst the LGE, that is situated more dorsally, gives rise
to the caudate and putamen [10, 11]. The LGE is further
divided into the dorsal LGE (dLGE) and the ventral LGE
(vLGE) on the basis of regional gene expression, which is
discussed later.
Within the surrounding neural epithelium of the devel-
oping telencephalon, there are two proliferative zones, which
are shown in Figure 3, the ventricular zone (VZ), which is
positioned on the perimeter of the lateral ventricles, and the
subventricular zone (SVZ) (unique to the telencephalon),
which extends from the basal region of the VZ [12]. It is in
the proliferative zones of the ventral telencephelon that both
projection neurons (including MSNs) and γ-aminobutyric
acid (GABAergic) interneurons are born before migrating
to the regions they populate in the adult brain. Specifically,
striatal projection neurons are born in the LGE and make up
nearly 90% of LGE neurons. Interneurons originating from
the LGE populate the cortex, olfactory bulb, and striatum,
whereas those from the MGE migrate to the cortex, GP, and
also the striatum [13–16].
4. Unzipping Telencephalon Development
The telencephalon is the most complex region of the mam-
malian brain and shows vast heterogeneity in terms of
its various neuronal populations, structures, and function.
Telencephalon development requires a variety of signals
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Figure 3: Coronal hemisections of the mouse telencephalon at E12.5 showing morphologically defined structures and the progenitor
subdomains. The ventricular zone (VZ) extends along the DV axis and contains proliferative neuronal precursor cells. The subventricular
zone (SVZ) (shown by the blue dashed lines) also contains precursor cells. Progenitor cells migrate radially and tangentially from these
zones to populate the specific areas of the brain. The dashed red lines indicate the approximate boundaries between distinct telencephalon
progenitor domains. Abbreviations: MGE/LGE medial/lateral ganglionic eminence; MP: medial pallium, DP: dorsal pallium LP: lateral
pallium, VP: ventral pallium. Picture taken from [15].
secreted from surrounding signalling centres to ensure
the correct positional identity of the neurons, which will
populate the adult forebrain. Several gene families are
involved in coordinating the initial events for telencephalon
patterning: principally fibroblast growth factors (FGFs),
bone morphogenic proteins (Bmps), Wnts (originated from
the drosophila gene wingless), retinoic acid (RA), and sonic
hedgehog (Shh). These genes are responsible for activating
downstream factors that enable signalling cascades to be
initiated that allow cells to gain a positional and molecular
identity [17]. It is likely that only a proportion of the factors
required for neuronal identity have so far been identified,
and the precise way in which such factors interact to
specify the timing and terminal diﬀerentiation of particular
neuronal subpopulations is not yet defined. However, there
have been clear advances in knowledge in this area over the
last few decades and we summarise here what is known about
some of the key factors so far identified as being involved in
striatal development.
5. FGF8
FGFs are ligands that activate several pathways, for example,
Ras Map kinase (MAPK) pathway upon binding FGF
receptors (FGFR) 1, 2, or 3 [18] and at least 5 FGF proteins
have been indentified in CNS development [19]. Fgf8 is
expressed rostrally from the anterior neural ridge (ANR) in
mammals and has roles in proliferation and cell survival. In
addition, it has been shown that Fgf8 regulates the expression
of forkhead box protein G1 (FOXG1) (previously bf1), a
rostral forebrain marker. It was shown that FGF8 could
renew Foxg1 expression in mouse explants that had the ANR
removed and secondly that inhibitors of Fgf8 reduced Foxg1
expression in neural plate explants [20, 21]. In addition,
reduction in Fgf8 leads to rostral truncations and midline
defects in the developing forebrain [22]. In Fgf8 null mice
(Fgf8−/−), the telencephalon was smaller than in wild-type
(WT) littermates and exhibited patterning abnormalities
[22–24]. Specifically, loss of function studies showed that the
MGE and LGE are absent, and there was loss of genes found
in the ventral regions, for example, Nkx2.1 and Dlx2 and
an expansion of the dorsal marker Pax6 [23]. These results
suggest a role for Fgf8 in ventralisation of the telencephalon.
However, it seems unlikely that Fgf8 is the sole factor involved
in the induction of rostral forebrain development due to the
continued presence of the telencephalon in Fgf8−/−or FGFR
null mutants [22]. One explanation for the telencephalon
still remaining in these mutants is that compensation is
achieved by other Fgfs expressed at the same time. However,
others in the field are of the opinion that overlapping
Fgf expression profiles do not exist and that each Fgf
has exclusive roles in telencephalon development [25, 26].
Therefore, the reason the telencephalon is not lost completely
in the Fgf8 mutant is that Fgf8 alone is not essential for
telencephelon generation [26, 27]. However, the fact that
beads soaked in FGF8 added to anterior neural explants
lacking an ANR promote expression of Foxg1 suggests FGFs
are necessary for telencephalon induction [20].
Recently, work supporting the gain of function studies
has allowed greater insight into the role of FGFs and FGFR
in telencephalon development. Triple FGFR knockouts have
shown that prior to telencephalon development at E10.5,
embryos showed abnormalities in the anterior structures and
by E12.5, a time when the telencephalic structures should be
morphologically distinguishable, mutants lacked all anterior
head structures and had no visible telencephalon except for
the dorsal midline [19]. In addition, Foxg1was not expressed,
together with complete absence of the ventral markers Dlx2
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and Nkx2.1. Unexpectedly, the dorsal marker Emx1 was also
absent suggesting that FGF has a role in forming the dorsal
telencephalon in addition to the ventral telencephalon [19].
The phenotype of the FGFR triple knockout was
markedly more severe than the mild phenotype observed in
single or double receptor mutants [18]. This supports the
argument that these receptors do compensate for each other
and do not have exclusive roles. However, this compensation
is not absolute given that a mild phenotype was still evident
in single or double mutants. This suggests the compensating
receptors can function, but as they are not the first choice
for the ligand, they produce signalling cascades at lower
eﬃciencies [19]. Therefore, results from the diﬀerent combi-
nations of FGFR mutants suggest that the FGFR1 receptor is
responsible for the majority of signalling, but it is the overall
levels of FGF signalling that operate to initiate, pattern, and
sustain early telencephalon development as a whole rather
than specific ligands patterning diﬀerent areas [19]. What is
left to be answered is if the FGFs function as morphogens or
independent to a concentration dependant gradient.
Foxg1 and Fgf8 are both expressed at approximately the
same time in the ANR (∼E8) and function through a tightly
linked positive feedback loop [19, 20]. FGF signalling is
suﬃcient and necessary for Foxg1 expression, and Foxg1 is
necessary for Fgf8 expression [20]. However, the diﬀerent
phenotypes between Foxg1 mutants and the FGFR triple
mutant suggest that both genes must function at least
partially through independent genetic pathways, the details
of which are still unknown [19].
6. SHH
SHH is a member of the hedgehog (Hh) family of secreted
proteins and acts as a morphogen that is first secreted from
the notochord, which underlies the posterior structures of
the brain, following which expression is from the overlying
neural plate [6, 27, 28]. By E9.5 Shh is expressed in
neural epithelium of the ventral telencephelon [29], and by
E12 it is expressed in the mantle zone and is no longer
detectable in the neuroepithelium [30]. Shh operates through
a concentration gradient that spans the DV axis at diﬀerent
time points to confer diﬀerent neuronal identities on the
developing precursors, and expression is first seen in the
ventral telencenphelon from E11.5 [31, 32]. SHH expression
directs neural progenitors to a ventral fate and importantly
is both necessary and suﬃcient to induce specific ventral
forebrain markers [32–34]. Shh is expressed in the ventral
telencephalon and is thought to maintain Fgf8 expression
[32, 35] as well as induce expression of forebrain markers.
Specifically, SHH activates several TFs including Nkx2.1 [36,
37], Gsx2 (formerly Gsh2) [38–40], and Pax6 [41].
SHH acts as a ligand for a pathway involving two
transmembrane proteins, patched (Ptc) and smoothened
(Smo). Normally, Ptc is bound to Smo and the pathway is
inactive as Smo is not free to activate the Glioma-associated
oncogene homolog 3 (Gli3). This is illustrated in Figure 4.
However, when SHH binds Ptc, Smo is de-repressed which
results in the Gli repressor (GliR) becoming activated (GliA)
and being able to translocate to the nucleus and activate gene
expression, as shown in Figure 4.
There are three members of the Gli family of zinc-
finger TFs, Gli1, Gli2, and Gli3 and all have been shown
to regulate SHH-dependant gene expression. Gli proteins
have both activator and repressor activities, the N-terminal
encodes a repressor function, and the C-terminal region
is required for positive activity [43]. It is believed that
the Gli3 protein functions principally in its repressor form
and it appears that its activity is negatively regulated by
Shh [44, 45], whereas Gli1 and 2 function primarily as
transcriptional activators [46, 47]. The negative regulation
by Shh on Gli3 is observed in the limb, where Shh inhibits
Gli3 from processing into its repressor form [43]. Analysis
of mouse mutants for each of the Gli genes (Gli1−/−),
Gli2−/−, and Gli3−/−) has shown that mice lacking Gli3 or
Gli2 show only slight defects in telencephelon development
[48], whereas mice lacking Gli3 have strong defects in dorsal
telencephelon patterning [49–51]. At the dorsal region of the
telencephelon, where the concentration of SHH is limited,
the Gli3 protein is cleaved from an activator into a repressor
form and promotes dorsal patterning [43]. It is the inhibition
of the Gli3 repressor complex in the ventral region that
facilities telencephalon development; therefore, the primary
function of Shh is to prevent the production of excessive Gli
repressors. However, as Gli3 has been shown to be able to
function as a weak activator of Shh in vivo [52], the question
recently investigated by Yu and colleagues [53] is whether this
protein (or either Gli1 or 2) has an activating role in ventral
telencephalon [53]. Recent work by this group suggests Gli
activators do have a role in specification, diﬀerentiation, and
positioning of some subgroups of telencephalon neuronal
progenitors that arise from the interganglionic sulcus [53],
but further experiments need to be carried out to learn more
about the role of Gli proteins as activators, and therefore this
paper will concentrate on the role of Gli3 as a repressor in
DV patterning.
The relationship between Shh and Gli3 has been shown
functionally through varying combinations of mutants. In
Shh−/− mutants, the ventral markers Dlx2, and Gsx2 were
reduced, whereas in Gli3−/− mutants the expression pattern
of these genes was extended into more dorsal regions [43].
Overall the Shh−/− mutant shows more severe telencephelon
abnormalities than the Gli3−/− mutant [49, 50]. In accord
with the loss of ventral markers in Shh mutants (Shh−/−),
there is a loss of ventral telencephalic cells leading to an
altered morphology of the ventral telencephalon together
with the ectopic expression of dorsal forebrain markers [33–
35, 43]. Specifically, the mutants lack any MGE development
as shown by the absence of Nkx2.1 [43]. In vitro, cultures of
telencephalon explants treated with SHH result in expression
of ventral markers such as Nkx2.1 [33]. The complimentary
gain of function experiments carried out in both fish and
mice has shown that SHH promotes ventral identity in
dorsal telencephalic cells in vivo with induction of the
ventral forebrain markers Gsx2, Dlx2 and Nkx2.1 [38,
54]. Importantly, conditional knockouts using a FoxG1-
Cre to knock-out Shh have allowed the optimal window of
signalling in telencephalon development to be investigated.
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Figure 4: The Shh pathway for target gene expression: (a) repressed pathway—when SHH cannot bind Ptc, ptc represses gene expression by
being bound to Smo. Smo cannot then activate the Gli complex meaning the target gene is repressed. (b) Induction pathway—when SHH
binds ptc, smo is released which allows the GliA to bind the DNA and activate gene expression. Abbreviations: SHH: sonic hedgehog, Ptc:
patched, Smo: smoothened, GliA: Gli Activator.
Fuccillo et al. [55] showed that if Shh is knocked-out at E8.5,
there are severe defects of all ventral telencephalic regions
[55]. However, in knockouts at E10-12 using a Nestin-Cre,
there are limited defects in ventral telencephalic patterning
and cortical interneurons are aﬀected rather than gross
patterning deficits [56].
In the Shh−/− and Gli3−/+ mutants, telencephalon
morphology is largely restored to WT, but regional gene
expression is not fully restored. The ventral marker Nkx2.1
is not rescued unless both copies of the Gli3 protein
are removed, suggesting Nkx2.1 is very sensitive to the
antagonism between Shh and Gli3 [43]. Also, in Gli3−/−
mutants, the expression of Nkx2.1 is not extended dorsally
like Dlx2 and Gsx2, nor can it be expressed ectopically
in the cortex when exogenous Shh is added. From this
Rallu and colleagues suggested that the Gli2 protein has a
complimentary role to Gli3. It is thought that Gli2 functions
as a weaker repressor and can repress the expansion of
Nkx2.1 in Gli3−/− mutants but is not strong enough to
prevent the expansion of the more ventral genes Dlx2
and Gsx2 [43]. Moreover, in the Shh−/− and Gli3−/−,
double mutant ventral markers such as Gsx2 and Dlx again
were largely restored to WT levels [43, 57]. In support of
this, Nkx2.1 expression was expanded in Ptc mutant mice
(Ptc−/−). In this mutant, Smo should be persistently de-
repressed and Gli proteins should remain in their activated
form, thus having a repressive eﬀect on Nkx2.1 expression
in the MGE [58]. However, the fact that Dlx2 and Gsh2
were restored in the absence of Shh signalling in this
mutant suggests that other genes and signalling pathways,
independent to Shh signalling, have a role in DV patterning
of the telencephalon [43].
In summary between E9 and E12.5, SHH acts mainly
by inhibiting the formation of the Gli3 repressor [43] and
contributes to the establishment of DV patterning [34, 55].
Secondly, SHH signalling also supports the expansion of
progenitors of the ventral telencephalon by inducing and
maintaining the expression of Nkx2.1 until at least E14 and
later into neurogenesis [56].
7. Retinoic Acid
RA is the biologically active form of vitamin A and has
been implicated in survival, specification, proliferation, and
diﬀerentiation during forebrain development [58–60]. Two
oxidation events occur to ensure RA is successfully derived
to function as a ligand for either RA receptors (RARs)
(RARα, RARβ and RARγ) or retinoid X receptors (RXRα,
RXRβ, and RXRγ) that belong to the steroid/thyroid receptor
superfamily [61]. Initially retinol dehydrogenases oxidate
retinol to retinaldehyde and then the rate-limiting enzymes,
retinaldehyde dehydrogenases (Raldh), are required to oxi-
date retinaldehyde to RA [62].
The first known source of RA in the developing striatum
is in the LGE at approximately E12.5 and is produced from
reactions mainly catalysed by Raldh3 [63]. It is not until E14
that RA and Raldh3 are obviously expressed in the LGE and
promote GABAergic neuronal diﬀerentiation by inducing
Gad67, an enzyme needed for GABA synthesis [64]. Raldh3
continues to promote GABAergic diﬀerentiation at E18.5,
and RA continues to be expressed into adulthood [64]. It has
also been reported that in vitro LGE-derived neurospheres
and human embryonic stem cells (hESCs) induce GABAergic
diﬀerentiation once RA was added to the media [64]. How-
ever, it is thought that the RA in the LGE is not only a product
from Raldh3-mediated reactions as Raldh3−/− mutant mice
do not show an obvious telencephalic phenotype [65]. It has
been shown that retinoids from the glia found in the LGE
are also functioning in striatal neuronal diﬀerentiation [66];
therefore, it is possible that these, and other sources not yet
known could be compensating for Raldh3.
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Furthermore, at this time the RARs α and β are present
in the ventral telencephalon, with RARβ preferentially ex-
pressed in LGE together with RXRγ [67]. In RAR β−/−
mutant mice, there is a loss of striatal-enriched tyrosine
phosphatase mRNA, a gene regulated by RA in the striatum
[67], and a reduction of striatal dopamine and cAMP-
regulated protein (DARPP-32) positive neurons together
with dynophin, μ-opioid receptor (MOR1), and tyrosine
hydroxylase (TH) compared to WT mice [59, 67]. It has also
been shown that when chick explants of LGE are treated
with RAR antagonists, LGE specification is prevented [58].
The complimentary experiment shows that when exogenous
RA was added to dorsal explants, LGE was evident instead
of MGE [58]. Additionally, supplementation of RA to LGE
cultures showed an increase in DARPP-32 positive neurons,
whilst there was no eﬀect seen in the MGE relevant to
increasing doses of RA [66]. Moreover, blocking RA in
chick embryos prevents the expression of Meis2 which is
expressed in progenitor cells of the intermediate zone of the
telencephalon and is the earliest known marker of striatal
precursors [66]. Taken together, these results confirm the
importance of RA in LGE specification.
As well as being important in embryonic development,
RA expression remains in the forebrain throughout adult
life and has been shown to maintain the expression of
Fgf8 and Shh in this region, as when RA is removed, Fgf8
and Shh expression is lost [59, 60]. It has recently been
proposed that Nolz1, a zinc finger TF that is expressed in
the proliferative SVZ in LGE precursor cells, is implicated
in RA signalling [68]. At E12.5 Nolz1-induced neurogenesis
partially depends on RA signalling as it has been shown
that this TF activates the RAR β receptor in LGE-derived
neural precursor cells and that this eﬀect was inhibited when
RA was removed [68]. However, Nolz1 expression was not
aﬀected in Raldh3 mutant mice (Raldh3−/−), which lacks RA
in the LGE, or when a vitamin A deficient diet was fed to
the mothers [63, 69] suggesting RA is not essential to Nolz1
expression throughout development and is only needed to
induce early expression. RA activates Nolz1 to induce initial
neurogenesis during early striatal development at E12.5 but
is not suﬃcient for its maintenance beyond this time [68].
Also, it has also been shown that Nolz1 contributes to later
striatal development by working downstream of Gsx2 to
activate the RARβ receptor.
8. Wnt Signalling
Wnts belong to the wingless protein family and are a class
of ligands that are crucial in embryogenesis and have been
implicated in CNS development. Wnts can signal through
three diﬀerent pathways: the canonical pathway, the planar
cell polarity pathway, and the calcium pathway and it is
the canonical pathway that is important in telencephalon
development. In the canonical pathway, β-catenin is indi-
rectly activated by a WNT ligand binding to the cell surface
receptor, Frizzled. Upon binding, frizzled activates its intra-
cellular component dishevelled (Dsh) that dephosphorylates
β-catenin preventing its degradation by the axin-glycogen
synthase kinas 3β (GSK3β) complex (in the absence of
WNT signalling, β-catenin is phosphorylated by the GSK3β
complex and degraded). β-catenin then translocates to the
nucleus where it can activate the transcription of Wnt target
genes such as T-cell factors (TCF), which in turn regulate
genes such as c-myc. This pathway is shown in Figure 5.
Wnts are part of the cohort of caudalizing factors that
are involved in the initial AP orientation of the neural
plate and are crucial for the generation of the dorsal
telencephelon [70]. Specific concentrations of WNTs are
needed to further refine regional patterning and to induce
the expression of Pax6, a dorsal telencephelon marker [71].
A reporter line carrying a LacZ reporter gene under the
control of β-catenin/TCF response elements showed that
WNT signalling is active in the pallium at E11.5 and E16.5
but not in the subpallium [72, 73]. In the absence of
canonical signalling, there was ectopic expression of Gsx2,
Dlx2, and Ascl1 (formerly Mash1) in dorsal telencephelon
together with downregulation of the dorsal markers Emx1, 2
and 3 [73]. This ectopic expression of ventral genes facilitated
the cells of the dorsal telencephelon to adopt a ventral fate,
therefore allowing these cells to have the potential to become
GABAergic projection neurons [73]. Therefore, this work
in mice has shown that WNT signalling is necessary for
ensuring the correct molecular characterisation, and thus
morphology, of the dorsal telencephelon before the onset
of neurogenesis and that inhibition of WNT signalling is
necessary for subpallidal development [73]. In addition, gain
of function experiments carried out in chicks has shown the
importance of Wnt gene expression in dorsal telencephelon
patterning. Using chick explant cultures, Gunhaga et al. [71]
showed that Wnt3a or Wnt8 expression can convert the
ventral telencephalic cells into Pax6 and Ngn2 positive cells
at the expense of Ascl1 and Nkx2.1 [71].
9. BMPs
Although BMP inhibition is required for neuronal devel-
opment, graded concentrations are necessary in the neural
plate to establish medial-to-lateral patterning [42]. BMPs
belong to the TGFβ family of secreted proteins. It is thought
that BMPs are also needed to dorsalize the telencephalon
and restrict ventral telencephalic development. Forebrain
patterning was repressed in forebrain explant cultures when
BMPs were added as shown by inhibition of Foxg1, Nkx2.1,
and Dlx2 [74]. Similarly beads soaked in BMP4 or BMP5
that were implanted into the neural tube of a chick forebrain
induced dorsal markers, for example, Wnt4 and repressed
ventral markers [75]. Additionally, when the telencephalic
roof plate (a source of BMPs) was ablated, there was a
reduction in cortical size and a decrease of one of the most
dorsal cortical markers, Lhx2 [76]. BMPs are inhibited by
several factors including chordin and noggin. In mice that
lacked both copies of the chordin gene (chordin−/−) and one
copy of the noggin gene (noggin+/−), a dorsal, rather than
ventral telencephalon was evident. However, this eﬀect may
not be direct because of an increase in BMP and may be in
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Figure 5: The canonical Wnt pathway for target gene expression. (a) When a WNT ligand is absent, β-catenin is phosphorylated by the
Gsk3β complex and is targeted for degradation and there is no gene expression. (b) When a Wnt ligand binds Frizzled, Dsh is activated
and inhibits the axin-Gsk3β complex phosphorylating β-catenin enabling it to translocate to the nucleus and can activate TCF which can
activate gene expression. Abbreviations: APC: adenomatous polyposis coli, Dsh: Dishevelled; GSK3β: glycogen synthase kinase 3 β; TCF:
T-cell factor.
part due to the decreased levels of Shh and Fgf8 expression in
the forebrain caused by increased BMP levels [77].
10. Foxg1
Foxg1 is a member of the winged helix family of TFs and is
the earliest recognisedmarker of the telencephalon [78]. This
TF was first identified in the rat brain, where it was shown
that its expression was restricted to the telencephelon [78].
By E8.5 Foxg1 is expressed in the neural tube, specifically
in the anterior plate cells that are fated to contribute to
the telencephalon [20, 79], and functions to establish and
subdivide the telencephalon.
Foxg1−/− mutant mice show no morphological diﬀer-
ences in the size of the developing telencephalon at E10.5.
However, the ventral markers Ascl1, Nkx2.1, Gsx2, and
Dlx1/2 are absent, and instead the dorsal markers, Emx2 and
Pax6, are expressed throughout the telencephelon [80, 81].
It has also been shown that Fgf8 was reduced in the mutant
telencephalon at E10.5 [81]. By E12.5 there were considerable
morphological diﬀerences in the ventral telencephalon of
the mutant when compared to WT; notably the GEs were
absent but there were no defects in the dorsal area [80,
81]. A reason for the absence of the ventral telencephalon
in these mutants is the loss of proliferating cells in this
region (shown through BrdU staining) with telencephalic
proliferation being restricted to the dorsal region [80]. This
decrease in proliferation could be a direct consequence of the
lack of Foxg1 expression or could be due to eﬀectors of Foxg1
not being able to function optimally.
It has also been shown that Foxg1 coordinates signalling
pathways of SHH and WNTs, which are required for the
development of the subpallial and pallial telencephalon,
respectively, and have been described above [82]. Dorsal
identity is prevented by Foxg1 inhibiting the Wnt pathway,
further confirming the role of Foxg1 in ventral telencephalon
induction in an independent way to SHH. Manuel et al.
[17] cultured cells from Foxg1−/− mice and showed that
the addition of SHH and FGF8 alone could not induce
the expression of other ventral telencephalon genes. Also,
further experiments where Foxg1−/− cells were grafted into
Foxg1−/−/Foxg1+/+chimeras, showed that the mutant cells,
were specified abnormally, did not integrate with WT cells
and expressed dorsal rather than ventral markers [17].
Recently, Manuel et al. [83] have also shown that the
reason for mutant cells behaving diﬀerently is due to them
having an increased cell cycle, something initially reported
by Martynoga et al. [81]. Specifically, Manuel and colleagues
have shown that this is due to a decrease in Pax6 expression,
a cell cycle organiser. Upon addition of PAX6, the mutant
phenotype was partially rescued [83]. This work suggests that
Foxg1 not only promotes the production of ventralising cues,
but has a cell autonomous role in regulating Pax6 [83]. Foxg1
is crucial in forebrain development and is absolutely required
for the regulation of telencephalic identity.
11. Dorsoventral (DV) Organisation of the
Developing Telencephalon
As discussed already, the developing telencephalon is divided
into the dorsal region, and the ventral region and these areas
can be defined on a morphological and genetic basis. In
the dorsal telencephalon Pax6, Neurogenin (Ngn) 1/2 and
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Figure 6: Schematic coronal section through the developing telencephalon at E12.5—the dorsal and ventral subdomains are shown and
defined by unique gene expression patterns. Dorsal telencephalic markers shown are Emx1/2, Ngn1/1, and Pax6. The ventral telencephalic
markers shown can be split into identifying the LGE or MGE. Mash1(Ascl1), Gsx1/2, and Dlx1/2 are associated with the LGE (specifically the
vLGE), andNkx2.1 is associated with theMGE. Some of the gene interactions are shown on the diagram. One of the important interactions is
between Pax6 andGsx2; these genes work together to ensure the subpallalial/pallial border is maintained. Arrows denote positive interactions;
T-bars denote inhibitory control. The green arrows represent the genetic signalling that has been unravelled in more recent data and occurs
at later time points. Figure adapted from [42].
Emx1/2 are expressed; in the ventral telencephalon, Gsx2,
Asc1, Dlx1/2, and Nkx2.1 are expressed, as shown in Figure 6
[84]. The pallial genes will only be discussed briefly in the
context of them as markers, not to fully elucidate their
role in cortical development. Emx1/2 expression profiles are
restricted to the most dorsal region of the cortex with no
expression seen in the ventral cortical region. Ngn 1 and 2
are basic helix loop helix (bHLH) TFs which are expressed
throughout the cortex together with Pax6. In the absence of
Ngn expression, Ascl1 is ectopically expressed in the dorsal
telencephalon thus priming these cells to adopt a ventral
fate and becoming GABAergic rather than glutamatergic
neurons. Therefore, the role of Ngn1/2 is to maintain the
DV boundary in the developing telencephalon and to inhibit
ventral gene expression such as Ascl1 [24, 85].
Homeodomain gene interactions are crucial inmediating
DV patterning and importantly, in setting up regional
subdivisions within the developing telencephalon, as well
as within the ventral telencephelon, and are principally
regulated through Shh [36–41]. Pax6 and Gsx2 are two
members of this homeodomain family [86]. These proteins
have overlapping expression profiles and work in synergy to
ensure the subpallium-pallium border is maintained [39].
Their expression profiles mirror each other; Pax6 is expressed
in a dorsal (high) to ventral (low) gradient and Gsx2 is
expressed in a ventral (high) to dorsal (low) gradient [87].
The embryonic patterning role of Pax6 was initially iden-
tified through genetic mapping of the classical “small eye”
(sey) mouse mutant [88]. Pax6 is needed for cortical
development and to establish the subpallial-pallial border
and is initially detected in the developing forebrain at E8
[89]. It is not until the neural tube stage that expression
is downregulated in ventral regions simultaneous with the
up regulation of Nkx2.1 in this region, thus instantaneously
setting up the DV ventral border on the basis of diﬀerential
gene expression [37, 38, 90]. In Pax6 mutant mice (Pax6−/−),
there is a shift in the cortical-striatal boundary [91] and
the cortical markers Ngn1/2 and Emx1 are downregulated,
and Dlx1/2 [39, 41, 92], Ascl11 [39, 41] and Gsx2 [39] are
ectopically expressed in dorsal regions of the telencephalon.
Nkx2.1 also expands dorsally into the LGE shifting the LGE-
MGE border [41].
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Gsx2 is first detected in the developing forebrain between
E9 and E10 and is expressed in the LGE. Gsx2 mutants
(Gsx2−/−) have the opposite phenotype to that seen in Pax6
mutants; there is ectopic expression of Pax6 and Ngn2 in
the LGE accompanied by the loss of Ascl1 and Dlx2 [38–
40]. On the whole, there was a reduction in the size of the
LGE at E12 [93], which by E18.5 led to a reduction in the
size of the striatum [94] and reduced expression of striatal
projection neurons confirmed through a marked decrease in
DARPP-32 and the earlier MSN marker, Forkhead box P1
(FoxP1) [38–40, 95]. However, there was a slight increase
in the striatal-matrix marker calbindin [95]. These results
suggest that Gsx2 is a crucial inducer of Ascl1, Dlx1, and
Dlx2 whilst repressing dorsal character and is implicated in
the diﬀerentiation of calbindin positive neurons. However, in
mice that lack both Gsx2 and Pax6 (Gsx2−/− and Pax6−/−),
the phenotype observed was more subtle than the single
mutations as is the case in Shh−/−Gli3−/− double mutants
[38]. This suggests that other genes are also important in
mediating DV patterning and positioning of the pallial-
subpallial boundary.
Gsx1, a gene closely related to Gsx2, is also expressed
in the ventral telencephalon but unlike Gsx2 its expression
is restricted to the ventral most region of the LGE [96].
It is thought that Gsx1 can partially compensate for the
phenotype observed in Gsx2−/− mutants [95, 97, 98]. In the
Gsx2−/− mutant, Gsx1 expression spreads throughout the
LGE between E11 and E14.5 and shows similar expression
patterns to Ascl1 in the LGE [95]. DARPP-32 expression is
lost in both Gsx2−/− /Ascl1−/− and Gsx2−/− Gsx1−/− double
mutants suggesting Ascl1 has a role in regulating Gsx1 to
compensate for Gsx2 in Gsx2−/− mutants [95]. Until recently
the role of Gsx1 has remained elusive as no phenotype has
been discovered through using knockouts. Pei et al. [99] have
shown that Gsx1 and Gsx2 diﬀerentially regulate the matura-
tion of LGE progenitors. Gain-of-function experiments were
carried out to distinguish if these two closely linked genes do
indeed carry out diﬀerent roles in the LGE or ifGsx1 is simply
a “backup” for Gsx2. Results showed that Gsx2 maintains
LGE progenitors in an undiﬀerentiated position before Gsx1,
in part through the downregulation of Gsx2, directs the
progenitors to acquire a mature neuronal phenotype [99].
This is shown in Figure 6. These novel results indicate
that the Gsx genes regulate LGE patterning through a
controlled balance of signalling allowing proliferation and
diﬀerentiation of neuronal progenitors [99].
Ascl1 is also a member of the bHLH family of TFs. It
has a primary role in the correct development of the ventral
telencephalon and relies on Gsx2 for normal expression [38–
40, 100]. In contrast to Ngn1/2 that is expressed in the dorsal
telencephelon, Ascl1 is expressed throughout the ventral
telencephalon and ASCL1 protein is seen in the VZ and SVZ,
where neuronal precursor cells reside [101]. When Ascl1
was ectopically expressed in the dorsal telencephalon, it was
able to induce neurons to express Dlx1/2 at the expense of
cortical markers [24]. Ascl1 interacts with Dlx1/2 that in turn
activates GAD/67, the rate-limiting enzyme for GABAergic
synthesis, and the two combined function to facilitate
GABAergic diﬀerentiation in the telencephalon [85, 100].
However, in Ascl1 knockout experiments (Ascl1−/−), Dlx
and Gad/67 are still expressed in the ventral telencephelon
[100]. Together with the fact that these developing neurons
can still acquire a GABAergic phenotype in the absence of
Dlx1 and 2, this suggests an element of redundancy in this
signalling pathway and/or the involvement of other genes
not yet identified. Expression of Gsx2 in the Ascl1−/− mutant
is the same at E12.5, but by E18.5 there is an increase in
Gsx2 expressing cells suggesting that Ascl1 has the additional
role of repressing Gsx2 function later in development. This
is shown in Figure 6 [94]. Ascl1−/− mutants also show a
reduction in the number of early born striatal (cholinergic)
and cortical (GABAergic) interneurons and a reduction in
size of the MGE [100]. This phenotype can be explained by
the initial loss of precursor cells in the SVZ, subsequently
leads to a decrease in neurons populating the mantle zone
[100, 102]. Conversely, TH, D2R, and enkephalin positive
neurons are only slightly reduced in this mutant. This is
expected considering the LGE is only partially reduced [102].
However, Wang et al. [94] suggest that the reason for the
Ascl1mutant not giving a more severe phenotype is thatGsx2
signals through another bHLH TF.
From these experiments, it can be concluded that Ascl1
has the dual role of specifying precursors and controlling
the timing of their diﬀerentiation, principally in the MGE
and possibly has a role in the LGE, although it is not crucial
in this later eminence [98, 102]. Recent experiments by
Castro and colleagues have looked more closely into the pre-
cise mechanisms by which Ascl1 controls proliferation of
neuronal precursors [103]. Gene expression analysis carried
out from embryonic brains and neural stem cell cultures
showed that Ascl1 has a role in regulating genes concerned
with cell cycle progression and ultimately showed that
there was a direct association between neural progenitor
expansion and the corresponding phases of cell cycle exit
and neuronal diﬀerentiation [103]. What is clear is that
Ascl1 is autonomously involved in patterning of early
telencephalic progenitors (∼E10.5) and nonautonomously
involved in repressing the diﬀerentiation of adjacent progen-
itors through Notch signalling [100]. After Ascl1 has been
expressed to aid neurogenesis, Dlx1 and 2 repress Ascl1 and
subsequent notch signalling to promote terminal neuronal
diﬀerentiation [104].
The Dlx family bears homology to the drosophila distal
less-homeobox gene family of which there are 6 murine
members, 4 of which are expressed in the developing MGE
and LGE [105]. Dlx1 and Dlx2 are expressed by subsets
of cells in the VZ and by most cells in the SVZ and
switch oﬀ as cells start to diﬀerentiate [101, 106]. Dlx5
and Dlx6 are expressed in the SVZ and mantle zone only
[13]. Single mutations of Dlx1 or 2 show no noticeable
forebrain defects; although in the absence of both Dlx1 and
2; there is arrested migration of matrix neurons within the
SVZ [13, 106]. However, striatal development is not stopped
completely, and this phenotype suggests other genes are
involved in neuronal migration or that other genes such
as Gsx2 and Ascl1 are compensating somehow by directly
activating the targets of Dlx1 and 2. A series of experiments
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fromRubenstein’s lab have sought to identify other genes and
TFs that could function downstream and upstream of Dlx1/2
to control LGE specification and diﬀerentiation through a
series of gene expression arrays and in situ hybridisations
[107]. It is likely that further work will continue to find
relationships between these genes and Dlx1 and 2.
As mentioned above, Dlx1 and 2 activate GAD67, an
enzyme needed for GABA synthesis and found in neuronal
precursors of the SVZ and neurons of the mantle zone in
the ventral telencephalon [100], and in Dlx1/2−/− there are
decreased levels of GAD67 in the dLGE [108]. It is has
been suggested that Dlx1/2 indirectly activate GAD67 and
that cooperation with other proteins is needed to promote
a GABA neuronal phenotype [109]. Necidin is a maternally
imprinted gene and is only expressed in the paternal allele
[110, 111]. Mutant mice that lacked the paternal necidin
allele showed a significant decrease in the diﬀerentiation of
GABAergic neurons in vivo and in vitro, therefore suggesting
that necidin facilitates the specification of GABAergic neu-
rons in cooperation with Dlx proteins [109].
Nkx2.1 is expressed exclusively in theMGE and is another
homedomain protein. The primary role of Nkx2.1 is in ven-
tral specification of the telencephalon where it acts to repress
LGE identity, and it is also important in the development
of striatal interneurons [7, 37]. Nkx2.1 is induced by Shh at
E8 [33], and as earlier mentioned, inhibition of Shh leads to
reduced expression ofNkx2.1 and dorsalisation of the ventral
embryo [34]. In the Nkx2.1 mutant mouse (Nkx2.1−/−),
there are a lack of MGE derivatives and a DV switch of the
MGE as it shows properties similar to the LGE rather than
the MGE, for example some cells have been shown to express
DARPP-32 [37]. The loss of Nkx2.1 also showed a reduction
of GABA and calbindin positive neurons from the cortex
[37]. Additionally, generation of an (Nkx2.1−/−) mouse with
the addition of a DlxtauLacZ reporter gene showed loss of
early migration of Dlx2-expressing progenitors [30].
It is clear that DV patterning of the telencephelon
requires the precise orchestration of several genes and TFs
that work together to ensure the correct development of the
striatum. It is likely that further experiments using the ever
expanding range of genetic tools will further disclose the
roles of genes already known, further elucidate the signalling
pathways they operate through, and identify novel genes that
have a functional role in striatal development and that can be
used as specific regional markers [112–114].
12. Conclusion
This paper has aimed to summarise and organise research
that is being carried out to understand the genetic mecha-
nisms controlling striatal development. However, it is clear
that there are still many pieces of the jigsaw to be found
and fitted into the gaps of this puzzle. The more that
is known about the development of the striatum, and,
importantly, the development and diﬀerentiation of striatal
MSN neurons, the more precise the protocols can be to
direct the fate of renewable cell sources, such as embryonic
stem cells, to a functional MSN phenotype for use in
cell replacement therapy for HD. An additional aspiration
is to identify specific genes to detect MSN precursors
rather than relying on markers of terminally diﬀerentiated
MSNs, such as DARPP-32. Earlier markers of putative MSNs
could be used to facilitate the generation and refinement
of neuronal diﬀerentiation protocols as well as tracking
neuronal diﬀerentiation in grafts.
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